Literature DB >> 10996307

Inhibition of influenza virus replication in cultured cells by RNA-cleaving DNA enzyme.

T Toyoda1, Y Imamura, H Takaku, T Kashiwagi, K Hara, J Iwahashi, Y Ohtsu, N Tsumura, H Kato, N Hamada.   

Abstract

Influenza virus replication has been effectively inhibited by antisense phosphothioate oligonucleotides targeting the AUG initiation codon of PB2 mRNA. We designed RNA-cleaving DNA enzymes from 10-23 catalytic motif to target PB2-AUG initiation codon and measured their RNA-cleaving activity in vitro. Although the RNA-cleaving activity was not optimal under physiological conditions, DNA enzymes inhibited viral replication in cultured cells more effectively than antisense phosphothioate oligonucleotides. Our data indicated that DNA enzymes could be useful for the control of viral infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996307     DOI: 10.1016/s0014-5793(00)01974-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

Review 1.  Nonviral gene transfer strategies for the vasculature.

Authors:  Jennifer L Young; David A Dean
Journal:  Microcirculation       Date:  2002-01       Impact factor: 2.628

Review 2.  Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.

Authors:  Ravinay Bhindi; Roger G Fahmy; Harry C Lowe; Colin N Chesterman; Crispin R Dass; Murray J Cairns; Edward G Saravolac; Lun-Quan Sun; Levon M Khachigian
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

3.  Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymes targeted to cleave HIV-1 TAT/Rev RNA.

Authors:  H Unwalla; A C Banerjea
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

4.  Electroporation-mediated delivery of catalytic oligodeoxynucleotides for manipulation of vascular gene expression.

Authors:  Elizabeth A Nunamaker; Hai-Ying Zhang; Yuichi Shirasawa; Joseph N Benoit; David A Dean
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-07-24       Impact factor: 4.733

5.  An efficient RNA-cleaving DNA enzyme can specifically target the 5'-untranslated region of severe acute respiratory syndrome associated coronavirus (SARS-CoV).

Authors:  Shuwen Wu; Junqiang Xu; Jiangxia Liu; Xuan Yan; Xiaodong Zhu; Gengfu Xiao; Lunquan Sun; Po Tien
Journal:  J Gene Med       Date:  2007-12       Impact factor: 4.565

6.  Systematic analysis of the role of target site accessibility in the activity of DNA enzymes.

Authors:  Graeme Doran; Muhammad Sohail
Journal:  J RNAi Gene Silencing       Date:  2006-07-28

7.  Design of efficient DNAzymes against muscle AChR alpha-subunit cRNA in vitro and in HEK 293 cells.

Authors:  Amr Abdelgany; M Khabir Uddin; Matthew Wood; Kazunari Taira; David Beeson
Journal:  J RNAi Gene Silencing       Date:  2005-10-14

8.  Sequence-specific cleavage of RNA in the absence of divalent metal ions by a DNAzyme incorporating imidazolyl and amino functionalities.

Authors:  Alexander V Sidorov; Jane A Grasby; David M Williams
Journal:  Nucleic Acids Res       Date:  2004-03-05       Impact factor: 16.971

Review 9.  RNA Secondary Structure as a First Step for Rational Design of the Oligonucleotides towards Inhibition of Influenza A Virus Replication.

Authors:  Marta Szabat; Dagny Lorent; Tomasz Czapik; Maria Tomaszewska; Elzbieta Kierzek; Ryszard Kierzek
Journal:  Pathogens       Date:  2020-11-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.